SCHEMBL3719040

SCHEMBL3719040

O=C(O)c1cn2c(N3CCC(O)C3)cccc2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
JAK1 P23458 2/20 0.37
PRKDC P78527 1/20 0.36
IRAK1 P51617 1/20 0.35
IRAK4 Q9NWZ3 1/20 0.35
GAA P10253 2/20 0.34
SCD O00767 2/20 0.34
SCD5 Q86SK9 1/20 0.34
ABL1 P00519 1/20 0.33
CFTR P13569 1/20 0.33
GNE Q9Y223 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
IDH2 P48735 1/20 0.33
NAPEPLD Q6IQ20 5/20 0.33
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GLA P06280 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3719037 1.00 PTGS1 (0.40) PTGS1PTGS2JAK1PRKDCIRAK1
SCHEMBL117350 0.78 PRKAB2 (0.37) PTGS1PTGS2PRKDCABL1CFTR
SCHEMBL117351 0.78 PRKAB2 (0.37) PTGS1PTGS2PRKDCABL1CFTR
SCHEMBL21516108 0.78 PTGS1 (0.42) PTGS1PTGS2GAAKDM4EALDH1A1
SCHEMBL2638003 0.73 TTR (0.53) PRKDCIRAK4GNENAPEPLDKDM4E
SCHEMBL17373798 0.73 TTR (0.53) PRKDCIRAK4GNENAPEPLDKDM4E
SCHEMBL28842909 0.72 PTGS1 (0.46) PTGS1PTGS2JAK1GAAGNE
SCHEMBL19996101 0.71 PRKCQ (0.43) PTGS1PTGS2IRAK4GAA
SCHEMBL29749599 0.71 KDM4E (0.39) PTGS1PTGS2GAAKDM4E
SCHEMBL9753622 0.69 PTGS1 (0.53) PTGS1PTGS2GAAGNENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010126745-A1 SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE AS β-SECRETASE INHIBITORS HIGH POINT PHARMACEUTICALS, LLC (US) 2010-11-04 WO disclosed